Thursday, 19 November 2026NewsWorldBusinessTech
Latest

NEJM Clinician Reports Whole-Body MRI Finds Abnormalities in 78%

Whole-body magnetic resonance imaging detected abnormalities in 78% of adults screened without an evidence-based indication, according to a meta-analysis published on October 29, 2026, by NEJM Clinician.

The evaluation pooled 17 studies involving 18,000 adults with an average age of 51 to gauge the utility of proactive scanning. Degenerative spinal disease and bone cysts emerged as the most frequent findings across the cohort, though the clinical value of uncovering these incidental issues remains uncertain.

Actionable Nonmalignant Findings

About 15% of individuals received nonmalignant results that were deemed “clinically actionable,” NEJM Clinician reported. These findings most commonly included hepatic steatosis, pulmonary nodules, and uterine fibroids.

Researchers examined these scans as direct-to-consumer marketing for early disease detection continues to grow. The analyzed studies contained minimal information regarding the baseline health characteristics of the patients involved in the screenings.

Preventive Health Screening Yield

In a separate retrospective observational study of 1,011 individuals published on November 19, 2026, in Cureus, researchers evaluated noncontrast, multiparametric screenings conducted at a single specialized clinic in Vancouver, Canada, between January and December 2022.

The investigation followed patients who underwent scans without known active cancer, utilizing routine clinical follow-up calls approximately 12 to 16 months later.

Diagnostic Metrics Across Demographics

Observed cancer detection varied across age groups and health histories in the preventive population. No malignancies were identified in participants younger than 35 years or older than 79 years.

The observed cancer detection percentage reached 1.39% for ages 35 through 49, rose to 2.54% for ages 50 through 64, and stood at 3.02% for ages 65 through 79. Individuals reporting a previous personal cancer history showed a detection percentage of 5.47%, while ever-smokers registered 3.90%.

Longitudinal Pediatric Dysplasia Analysis

In pediatric neurology, a retrospective longitudinal cohort study published on November 18, 2026, in Neuroradiology analyzed 21 patients with histopathologically confirmed focal cortical dysplasia type II. Conducted by Pierce Burr, Mathilde Ripart, Sophie Adler, and colleagues, the study assessed whether quantitative imaging features vary across serial scans.

Across body mass index categories in the broader cohort evaluation, the observed cancer detection percentage was 3.49% in normal-weight participants, representing 12 out of 344 individuals. The figure was 2.24% in overweight participants, covering 8 out of 357 individuals, 0.98% in participants with a body mass index between 30 and 34.9, representing 1 out of 102 individuals, and 1.82% in those with a body mass index of 35 or higher, encompassing 1 out of 55 individuals.

Out of 2,632 individuals scanned during the evaluation period, exactly 1,044 participants completed routine clinical follow-up calls. Thirty-three individuals possessing a known active cancer prior to the scan were excluded from this group.

A prospective trial at the Mayo Clinic, led by principal investigator John Amusan, is currently open for enrollment in Rochester, Minnesota. The trial aims to prospectively determine diagnostic accuracy, sensitivity, and specificity for next-generation whole-body magnetic resonance imaging in detecting lesions and assessing therapy response among patients with multiple myeloma and other bone-lesion cancers.

NEJM Clinician, part of the NEJM Group, delivers concise summaries of the most important developments in general medicine for a worldwide community of practitioners. It operates alongside flagship publications including The New England Journal of Medicine, NEJM Evidence, NEJM AI, and NEJM Catalyst.

Certain clinical factors exclude individuals from participating in the trial. Uncontrolled intercurrent illnesses, active infections, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmias, or specific psychiatric conditions that could limit study compliance prevent enrollment. Patients with severe lower back pain, uncontrollable tremors, or uncontrollable claustrophobia rendering them unable to tolerate magnetic resonance imaging procedures are excluded from participation.